- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
I am a Consultant Medical Oncologist at the Sussex Cancer Centre in Brighton, and Honorary Clinical Professor at the Brighton and Sussex Medical School. I trained in Genoa, Italy, where I qualified as MD in 1986. I started my career at Genoa’s National Cancer Institute, and also worked at the Santa Croce Hospital in Cuneo (Piedmont). In 2002 I moved to Swansea, UK, where I worked as a Consultant and Honorary Senior Lecturer until February 2018. I have served as Research Lead for the South West Wales Cancer Centre and as a member of the NCRI Breast Cancer Studies Group.
My main clinical and research interests are treatments of early and advanced breast cancer with chemotherapy, hormone therapy and targeted agents. I have contributed to several national and international clinical trials as Principal Investigator, Chief Investigator or Steering Committee Member. I am the Author or co-Author of more than 100 publications and in 2007 I was awarded a PhD from the University of Maastricht for research in the field of endocrine treatment of breast cancer.
Areas of interest
Breast cancer; chemotherapy; hormone therapy; targeted treatments
Medical secretaries
- Louise Ray
- Nuffield Health Brighton Hospital Warren Road Brighton BN2 6DX
- 01273 627054
- louiseraysecretary@gmail.com
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
-
X0001
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 0-7 days - (5-50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (1-5)